Judibat 40 Capsule is a combination pharmaceutical formulation containing Domperidone 30 mg and Esomeprazole 40 mg, designed for the management of gastrointestinal disorders. Domperidone, a peripheral dopamine D2 receptor antagonist, enhances gastrointestinal motility by increasing the movement of the stomach and intestines, thereby facilitating gastric emptying and reducing symptoms such as nausea, vomiting, and bloating. Esomeprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, providing effective relief from acid-related conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcers. The combination of these two agents in Judibat 40 Capsule offers a synergistic approach to managing upper gastrointestinal symptoms by addressing both motility and acid secretion abnormalities. This medication is indicated for patients experiencing dyspepsia, reflux esophagitis, and delayed gastric emptying. It should be used under medical supervision, with caution advised in patients with known hypersensitivity to either component, underlying cardiac conditions, or hepatic impairment. Judibat 40 Capsule is typically administered orally, with dosage and duration tailored to individual clinical response and physician guidance.